source
- FDA vows tighter review of foreign clinical trial data amid rising Chinese influenceTop FDA officials announced that the agency will intensify its oversight of clinical trial data generated outside the United States. The move is aimed at ensuring that foreign data meet the same st…
- H1 partners with Novo Nordisk to build AI-driven data foundation for clinical developmentClinical trials are becoming more complex and data‑heavy, but decision‑making processes have not kept pace. H1 and Novo Nordisk are collaborating to address this gap. Novo Nordisk’s StudyHub links…